Results 171 to 180 of about 5,164,002 (344)

Bob ten Cate: 'Ninety percent of the cells in our body are bacterial cells' [PDF]

, 2013
Bob ten Cate, Ruth M. Doherty
openalex   +1 more source

First-principles investigation of the electronic and thermoelectric properties of SiGe doped with Sn and one percent B

, 2021
Collins E. Ouserigha, G E Ogobiri
openalex   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Unit inconsistency in forensic blood and breath alcohol reporting. [PDF]

Forensic Sci Int Synerg
Olson A.
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Correction: Genotypic and phenotypic characterization of rare globin variants in Northern Guangxi, China. [PDF]

Front Immunol
Yang WJ, Kang QP, Liang LM, Zhou Q, Gong XM, Dou M, Huang CJ, Lin Y.   +7 more
europepmc   +1 more source

Percent Recovered [PDF]

, 2020
openaire   +1 more source

The Percent Volume Altered in Correction of Myopia and Myopic Astigmatism With PRK, LASIK, and SMILE [PDF]

, 2020
Damien Gatinel, Andreas Weyhausen, Mark Bischoff   +2 more
openalex   +1 more source

Targeting TNBC: core–shell polycationic polyurea dendrimers with inherent anticancer activity

FEBS Open Bio, EarlyView.
Core–shell polycationic PURE dendrimers were tested in TNBC‐derived tumor models. Both formulations selectively targeted TNBC and effectively reduced tumor volume. PUREG4‐OEI48 suppressed tumor growth without detectable toxicity, whereas PUREG4‐OCEI24, despite showing efficacy, induced hepatic toxicity.
Adriana Cruz, Bruna Abreu, Cindy Mendes, Catarina Freitas‐Dias, Filipe Gonçalves, Fernanda Silva, José Ramalho, Saudade André, Vasco D. B. Bonifácio, Jacinta Serpa   +9 more
wiley   +1 more source

Never Say 100 Percent

The International Journal of Biological Markers, 1988
A. van Dalen, M. Helfferich, J. Keuning
doaj   +1 more source